Patents by Inventor Peter Baxter

Peter Baxter has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Dynamic execution of parameterized applications for the processing of keyed network data streams
    Patent number: 10831509
    Abstract: A method is described for processing keyed data items that are each associated with a value of a key, the keyed data items being from a plurality of distinct data streams, the processing including collecting the keyed data items, determining, based on contents of at least one of the keyed data items, satisfaction of one or more specified conditions for execution of one or more actions and causing execution of at least one of the one or more actions responsive to the determining.
    Type: Grant
    Filed: August 28, 2017
    Date of Patent: November 10, 2020
    Assignee: Ab Initio Technology LLC
    Inventors: Oded Ravid, Larry Paul Rossi, Peter Baxter, Joel Gould
  • DYNAMIC EXECUTION OF PARAMETERIZED APPLICATIONS FOR THE PROCESSING OF KEYED NETWORK DATA STREAMS
    Publication number: 20180239615
    Abstract: A method is described for processing keyed data items that are each associated with a value of a key, the keyed data items being from a plurality of distinct data streams, the processing including collecting the keyed data items, determining, based on contents of at least one of the keyed data items, satisfaction of one or more specified conditions for execution of one or more actions and causing execution of at least one of the one or more actions responsive to the determining.
    Type: Application
    Filed: August 28, 2017
    Publication date: August 23, 2018
    Inventors: Oded Ravid, Larry Paul Rossi, Peter Baxter, Joel Gould
  • Stably human transfected rodent fibroblast cell line expressing human GABA-A recepotors, and cloned human GABA-A receptor subunit CDNA sequences
    Patent number: 5719057
    Abstract: The present invention relates to a stably co-transfected eukaryotic cell line capable of expressing a GABA-A receptor, particularly a human GABA-A receptor, which receptor comprises at least one alpha, one beta and one gamma subunit; to the cloning of novel cDNA sequences encoding the .alpha.-2, .alpha.-3, .alpha.-5, .alpha.-6 and .beta.-2 subunits of the human GABA-A receptor; and to the use of the cell line in designing and developing GABA-A receptor subtype-selective medicaments.
    Type: Grant
    Filed: April 5, 1995
    Date of Patent: February 17, 1998
    Assignee: Merck Sharpe & Dohme Ltd.
    Inventors: Karen Louise Hadingham, Beatrice le Bourdelles, Paul John Whiting, Peter Baxter Wingrove